MedPath

A clinical study to compare effect of draksha kalka with disodium hydrogen citrate ( syp Cital) in the symptomatic management of pittaj mutrakrucchra

Not Applicable
Conditions
Health Condition 1: N309- Cystitis, unspecified
Registration Number
CTRI/2019/03/018204
Lead Sponsor
PDEAs college of ayurved and research centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients presenting with cardinal symptoms of Pittaja mutrakruchhra mentioned

in Yogratnakar; chapter mutrakruchhrachikitsa

Patient having above 2 or more than complaints will be selected

ï?­ Peetamutrata (Yellow dark colour )

ï?­ Krichramutrata (Dysuria)

ï?­ Sadahamutrata (Burning micturation)

ï?­ Saraktamutrata (Hematuria)

ï?­ Muhurmuhurmutrata.( Frequncy of urination)

Exclusion Criteria

Known case of:

1.Obstructive pathology like prostatic enlargement

2.Dibetes mellitus

3.Sexually transmitted diseases

4.Tuberculosis

5.Metabolic disorder

6.Renal failure.

7.Patient of chronic cystitis with bladder wall changes.

8.Benign or malignant tumors of bladder

9.Urethral Stricture

10.Any infective pathology

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grading on the basis of Sadaha mutrapravruti, Sarakta mutrapravruti, Muhurmuhu mutrapravruti etc symptomatic reliefTimepoint: observing symptomatic relief in 7 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.To study adverse effects if any <br/ ><br>2.To observe efficacy of Draksha kalka in the management of pittaj mutrakrucchra <br/ ><br>3.To study effect of disodium hydrogen citrate (syp cital) in the management of pittaj mutrakrucchraTimepoint: Observation will be done before and after 7 days of treatment <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath